Androgen receptor targeted agents for castration resistant prostate cancer a review of clinical effectiveness and cost-effectiveness
The aim of this report is to review the comparative clinical effectiveness and costeffectiveness of varying treatment sequences of ARTA in patients with CRPC.
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2019, June 6, 2019
|
| Edition: | Version 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The aim of this report is to review the comparative clinical effectiveness and costeffectiveness of varying treatment sequences of ARTA in patients with CRPC. |
|---|---|
| Physical Description: | 1 PDF file (30 pages) illustrations |